Replies to post #101235 on Biotech Values

[oc631]

In biotech, this kind of purported delay without cause is often employed as a means of saving face. I’ll make you a gentleman’s bet that the phase-2b trial in gentotyoe-2/3 patients never starts

Roche chose to delay the trial and VRUS might not even know why. I'm not taking your bet, because I see your logic, but expect to hear from me when/if they do move forward.